Acolbifene

Known as: (2S)-3-(4-Hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-2H-1-benzopyran-7-ol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2015
0120042015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The purpose of this study was to assess the feasibility of using the selective estrogen receptor modulator (SERM) acolbifene as a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
INTRODUCTION We have recently reported that dehydroepiandrosterone (DHEA) increases the density of nerve fibers in the… (More)
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Novel agents for the endocrine therapy of breast cancer are needed, especially in order to take advantage of the multiple… (More)
  • figure 1
  • table 3
  • table 4
  • table 4
  • figure 2
Is this relevant?
2006
2006
Acolbifene (ACOL) is a fourth-generation selective estrogen receptor modulator (SERM) that has strong and pure antiestrogenic… (More)
Is this relevant?
2005
2005
To assess the specific estrogenic and/or androgenic effects of a potential novel hormone replacement therapy, we have examined… (More)
Is this relevant?
2005
2005
OBJECTIVE:The selective estrogen receptor (ER) modulator (SERM) acolbifene (ACOL), a potent and pure antiestrogen in the mammary… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2005
2005
Although approved for the treatment of hormone-dependent breast cancer as well as for the prevention of breast cancer in high… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2004
2004
Tamoxifen is the primary hormonal therapy for breast cancer and is also used as a breast cancer chemopreventative agent. A major… (More)
Is this relevant?